Literature DB >> 11005487

Colorectal cancer before the age of 40: a case-control study.

F Paraf1, S Jothy.   

Abstract

PURPOSE: Colorectal adenocarcinoma before the age of 40 is uncommon, and its prognosis is controversial, with many studies reporting a worse prognosis than in older patients and others showing no difference. The current study compared two groups of patients who had surgical resection for colorectal adenocarcinoma.
METHODS: The case group was composed of 34 patients younger than 40 (34 +/- 4) years. Detailed pathologic prognosis factors, tumor cell proliferation measured by proliferating cell nuclear antigen, survival, family history, and predisposing conditions were analyzed. Results were compared with a control group constituted of 34 patients older than 65 (75 +/- 6) years matched by gender, cancer site, and Dukes stage.
RESULTS: Tumor differentiation, presence of vascular and perineural neoplastic invasion, tumor growth pattern, tumor cell proliferation measured by proliferating cell nuclear antigen count, and survival according to the Kaplan-Meier method were not significantly different between younger and older patients. The only difference between the two groups was a higher prevalence of family history and predisposing conditions for colorectal cancer in younger patients (23 vs. 3 percent; P = 0.03).
CONCLUSION: This case-control study documents that pathologic features and prognosis of colorectal adenocarcinoma are comparable in patients younger than 40 years compared with older patients for identical stages. The higher prevalence of positive family history in younger patients suggests a different genetic background compared with older patients.

Entities:  

Mesh:

Year:  2000        PMID: 11005487     DOI: 10.1007/bf02237425

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

1.  Young-age onset of colorectal cancer in Israel.

Authors:  D Neufeld; B Shpitz; N Bugaev; M Grankin; J Bernheim; E Klein; Y Ziv
Journal:  Tech Coloproctol       Date:  2009-07-16       Impact factor: 3.781

2.  Racial differences in the anatomical distribution of colorectal cancer: a study of differences between American and Chinese patients.

Authors:  San-Hua Qing; Kai-Yun Rao; Hui-Yong Jiang; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Clinicopathological features of colorectal cancer in patients under 40 years of age.

Authors:  Jyrki T Mäkelä; Heikki Kiviniemi
Journal:  Int J Colorectal Dis       Date:  2010-03-09       Impact factor: 2.571

4.  Characteristics and long-term survival of colorectal cancer patients aged 44 years and younger.

Authors:  Zuli Yang; Liang Kang; Lei Wang; Jun Xiang; Guanfu Cai; Ji Cui; Junsheng Peng; Ping Lan; Jianping Wang
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

5.  Family history of colorectal cancer in Iran.

Authors:  Mahboobeh Mahdavinia; Faraz Bishehsari; Reza Ansari; Nasim Norouzbeigi; Ahmad Khaleghinejad; Mahshid Hormazdi; Naser Rakhshani; Reza Malekzadeh
Journal:  BMC Cancer       Date:  2005-09-05       Impact factor: 4.430

6.  Patterns of Sociodemographic and Clinicopathologic Characteristics of Stages II and III Colorectal Cancer Patients by Age: Examining Potential Mechanisms of Young-Onset Disease.

Authors:  Caitlin C Murphy; Hanna K Sanoff; Karyn B Stitzenberg; John A Baron; Jennifer L Lund; Robert S Sandler
Journal:  J Cancer Epidemiol       Date:  2017-01-23

7.  Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014).

Authors:  Mohammad Aziz Rasouli; Ghobad Moradi; Daem Roshani; Bahram Nikkhoo; Ebrahim Ghaderi; Bahman Ghaytasi
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  Significant Rise of Colorectal Cancer Incidence in Younger Adults and Strong Determinants: 30 Years Longitudinal Differences between under and over 50s.

Authors:  Dimitra Sifaki-Pistolla; Viktoria Poimenaki; Ilektra Fotopoulou; Emmanouil Saloustros; Dimitrios Mavroudis; Lampros Vamvakas; Christos Lionis
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.